The management of thoracolumbar burst fractures is controversial. The goal of our study was to evaluate whether the psychological factors or the late spinal deformities influence outcome and in particular quality of life following surgical treatment of burst fractures of the thoracolumbar spine. In a retrospective analysis, we evaluated outcome in 45 patients in whom burst fractures of the thoracolumbar spine without neurological deficits were surgically treated between April 2001 and November 2004. For this purpose, patient charts, surgery reports and x-ray images were analyzed consecutively. 29 patients could be examined physically and the outcome could be evaluated with VAS spine core, quality of life according to short-form 36 (SF36) and Beck Depression Inventory (BDI) with a minimum follow up of 30 months.Introduction
Material and methods
Pedicle screw pullout or loosening is increased in the osteoporotic spine. Recent studies showed a significant increase of pullout forces especially for PMMA-augmentation. With application of conventional viscosity PMMA the risk of cement extravasation is associated. This risk can be reduced by using radiofrequency-responsive, ultrahigh viscosity bone cement. 11 fresh-frozen lumbar vertebral bodies (VB) from 5 cadavers were collected and freed from soft-tissue and ligaments. By DEXA scan (Siemens QDR 2000) 8 VB were identified as severely osteoporotic (BMD 0.8 g/cm3), 3 VB were above this level. Two screws (6×45 mm, WSI-Expertise Inject, Peter Brehm, Weisendorf, Germany) were placed in the pedicles. Through the right screw 3ml of radiofrequency-responsive bone cement (StabiliT® ER2 Bone Cement, DFine, Germany) were injected via hydraulic cement delivery system (StabiliT® Vertebral Augmentation System, DFine, Germany). As control group, left pedicle screws remained uncemented. After potting the whole VB in technical PMMA (Technovit 4004, Heraeus Kulzer, Germany) axial pullout test was performed by a material testing device (Zwick-Roell, Zmart-Pro, Ulm, Germany).Introduction
Method
Radiofrequency Kyphoplasty (RFK) provides a new minimally invasive procedure to treat vertebral compression fractures (VCF). The purpose of this study was to investigate the functional outcomes, safety and radiographic outcomes after the treatment of painful osteolytic vertebral fractures treated with a novel minimally invasive procedure, RFK.Background
Purpose
The modular MRP-titanium system has proven to be valuable in quite problematic cases of hip revision arthroplasty with extensive femoral defects. The system allows intraoperative adaptation of implant length and antetorsion angle to the actual situation, a feature not provided by non-modular femoral revision implants.
Among the wide variety of bone substitutes presently available, pure β-tricalcium phosphate ceramics have become available (Biosorb®; Aesculap, Tuttlingen). During the first 12 months of a prospective clinical trial, Biosorb® products were implanted in 21 patients. The ceramics were used in a variety of clinical settings, ranging from pelvic osteotomies in children (n=9), to filling of bone cysts or osseous defects (n=4), to dorsal spondylodesis (n=6), as well as for the grafting of pseudarthroses (n=2). Average follow-up period was 13 (6–18) months. The β-TCP granules, when used as part of a composite graft in combination with autologous bone, were completely resorbed after an average period of 14 weeks, while the cubes required 12 to 15 months. The more massive wedges have shown only a decrease in size and radio density. Due to the ability of the cubes and wedges to bear loads of up to 30 MPa, they were successfully implanted during pelvic osteotomies to augment or completely replace the bicortical grafts. Complications or foreign body reactions were not noted. The osseointegration was found to be favorable for all forms. In light of the problems associated with autologous and allogeneic grafts, the use of synthetic bone substitutes will continue to increase. The combination of complete resorption, lack of risk of infection, and load sharing ability make the β-tricalcium phosphate implants a valuable addition to the spectrum of bone replacement products presently available. Their use in pediatric orthopedics could help avoid donor site morbidity including contour changes or growth disturbances, while providing a more stable graft. During the first phase of a prospective clinical trial, we have come to the conclusion, that the β-tricalcium phosphate ceramics represent a real alternative to other bone substitutes.